# EDGAR Filing Document

**Accession Number:** 0002025968
**File Stem:** 0000940400-26-011314
**Filing Date:** 2026-3
**Character Count:** 27550
**Document Hash:** 65ef622f56f6aa8d86d98c190f1f1761
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-26-011314.hdr.sgml**: 20260325

**ACCESSION NUMBER**: 0000940400-26-011314

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260130

**FILED AS OF DATE**: 20260325

**DATE AS OF CHANGE**: 20260325

**PERIOD START**: 20261031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon ETF Trust II
- **CENTRAL INDEX KEY:** 0002025968

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23977
- **FILM NUMBER:** 26791863

**BUSINESS ADDRESS:**
- **STREET 1:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 212-922-6400

**MAIL ADDRESS:**
- **STREET 1:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

## Series and Classes Contracts Data

### BNY Mellon Concentrated Growth ETF (Series ID: S000087737)

| Class ID   | Class Name                         | Ticker Symbol   |
|:---|:---|:---|
| C000253638 | BNY Mellon Concentrated Growth ETF | BKCG            |

## Nport-Ex

BNY Mellon Concentrated Growth ETF

SCHEDULE OF INVESTMENTS

January 31, 2026 (Unaudited)

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Equity Securities - Common Stocks — 96.2%** | **Equity Securities - Common Stocks — 96.2%** | **Equity Securities - Common Stocks — 96.2%** |
| **Capital Goods — 8.0%** | **Capital Goods — 8.0%** | **Capital Goods — 8.0%** |
| BAE Systems PLC, ADR<sup>(a)</sup> <br>| 35035 | 3807604 |
| Deere & Co. | 4961 | 2619408 |
| Eaton Corp. PLC | 9383 | 3297374 |
|  |  | **9724386** |
| **Consumer Discretionary Distribution & Retail — 9.8%** | **Consumer Discretionary Distribution & Retail — 9.8%** | **Consumer Discretionary Distribution & Retail — 9.8%** |
| Amazon.com, Inc.<sup>(b)</sup> <br>| 37525 | 8979732 |
| The Home Depot, Inc. | 8025 | 3006085 |
|  |  | **11985817** |
| **Consumer Durables & Apparel — 1.1%** | **Consumer Durables & Apparel — 1.1%** | **Consumer Durables & Apparel — 1.1%** |
| LVMH Moet Hennessy Louis Vuitton SE, ADR<sup>(a)</sup> <br>| 10355 | **1338694** |
| **Financial Services — 14.6%** | **Financial Services — 14.6%** | **Financial Services — 14.6%** |
| Blackrock, Inc. | 3582 | 4008043 |
| Intercontinental Exchange, Inc. | 17429 | 3028812 |
| Mastercard, Inc., Cl. A | 8961 | 4828097 |
| S&P Global, Inc. | 4157 | 2194023 |
| Visa, Inc., Cl. A<sup>(a)</sup> <br>| 11527 | 3709734 |
|  |  | **17768709** |
| **Food, Beverage & Tobacco — 3.1%** | **Food, Beverage & Tobacco — 3.1%** | **Food, Beverage & Tobacco — 3.1%** |
| Philip Morris International, Inc. | 21050 | **3777212** |
| **Health Care Equipment & Services — 3.3%** | **Health Care Equipment & Services — 3.3%** | **Health Care Equipment & Services — 3.3%** |
| Intuitive Surgical, Inc.<sup>(b)</sup> <br>| 7959 | **4013087** |
| **Insurance — 2.2%** | **Insurance — 2.2%** | **Insurance — 2.2%** |
| The Progressive Corp. | 12845 | **2671760** |
| **Media & Entertainment — 12.2%** | **Media & Entertainment — 12.2%** | **Media & Entertainment — 12.2%** |
| Alphabet, Inc., Cl. C | 27216 | 9213432 |
| Meta Platforms, Inc., Cl. A | 7872 | 5640288 |
|  |  | **14853720** |
| **Pharmaceuticals, Biotechnology & Life Sciences — 6.3%** | **Pharmaceuticals, Biotechnology & Life Sciences — 6.3%** | **Pharmaceuticals, Biotechnology & Life Sciences — 6.3%** |
| AstraZeneca PLC, ADR | 28855 | 2676879 |
| Eli Lilly & Co. | 4808 | 4986617 |
|  |  | **7663496** |
| **Semiconductors & Semiconductor Equipment — 20.9%** | **Semiconductors & Semiconductor Equipment — 20.9%** | **Semiconductors & Semiconductor Equipment — 20.9%** |
| ASML Holding NV | 5302 | 7544746 |
| NVIDIA Corp. | 60772 | 11615353 |
| Taiwan Semiconductor Manufacturing Co. Ltd., ADR | 10329 | 3414354 |
| Texas Instruments, Inc. | 13837 | 2982565 |
|  |  | **25557018** |
| **Software & Services — 10.2%** | **Software & Services — 10.2%** | **Software & Services — 10.2%** |
| Intuit, Inc. | 6659 | 3322308 |
| Microsoft Corp. | 17274 | 7432830 |
| ServiceNow, Inc.<sup>(b)</sup> <br>| 14814 | 1733386 |
|  |  | **12488524** |
| **Technology Hardware & Equipment — 4.5%** | **Technology Hardware & Equipment — 4.5%** | **Technology Hardware & Equipment — 4.5%** |
| Apple, Inc. | 21150 | **5488002** |
| &nbsp;&nbsp;&nbsp; **Total Equity Securities - Common Stocks** <br>(cost $56,392,342)<br>|  | **117330425** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**3**

------

*SCHEDULE OF INVESTMENTS (Unaudited) (continued)*

------

---

| | | | |
|:---|:---|:---|:---|
| Description | 1-Day <br>Yield (%)<br>| Shares | Value ($) |
| **Investment Companies — 3.7%** | **Investment Companies — 3.7%** | **Investment Companies — 3.7%** | **Investment Companies — 3.7%** |
| **Registered Investment Companies — 3.7%** | **Registered Investment Companies — 3.7%** | **Registered Investment Companies — 3.7%** | **Registered Investment Companies — 3.7%** |
| &nbsp;&nbsp;&nbsp; Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares<sup>(c)</sup> <br>(cost $4,533,596)<br>| 3.65 | 4533596 | **4533596** |
| **Investment of Cash Collateral for Securities Loaned — .8%** |  |  |  |
| **Registered Investment Companies — .8%** |  |  |  |
| &nbsp;&nbsp;&nbsp; Dreyfus Institutional Preferred Government Money Market Fund, Institutional Shares<sup>(c)</sup> <br>(cost $953,788)<br>| 3.65 | 953788 | **953788** |
| **Total Investments** (cost $61,879,726) | **Total Investments** (cost $61,879,726) | **100.7%** | **122817809** |
| **Liabilities, Less Cash and Receivables** | **Liabilities, Less Cash and Receivables** | **(.7%)** | **(884539)** |
| **Net Assets**  | **Net Assets**  | **100.0%** | **121933270** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*ADR—American Depositary Receipt*<br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> *Security, or portion thereof, on loan. At January 31, 2026, the value of the fund's securities on loan was $4,535,308 and the value of the collateral was* *$4,756,022, consisting of cash collateral of $953,788 and U.S. Government & Agency securities valued at $3,802,234. In addition, the value of collateral* *may include pending sales that are also on loan.* 

<sup>(b)</sup> *Non-income producing security.*

<sup>(c)</sup> *Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's* *prospectus.* 

*See notes to schedule of investments.*

**4**

------

Schedule of Investments

BNY Mellon Concentrated Growth ETF

January 31, 2026 (Unaudited)

The following is a summary of the inputs used as of January 31, 2026 in valuing the fund's investments:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1 -** <br>**Unadjusted** <br>**Quoted Prices**<br>| **Level 2- Other** <br>**Significant** <br>**Observable Inputs**<br>| **Level 3-** <br>**Significant** <br>**Unobservable** <br>**Inputs**<br>| **Total** |
| **Assets ($)** |  |  |  |  |
| Investments in Securities:<sup>†</sup> <br>|  |  |  |  |
| Equity Securities - Common Stocks | &nbsp;&nbsp; 117330425 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **117330425** |
| Investment Companies | &nbsp;&nbsp;&nbsp;&nbsp; 5487384 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **5487384** |
|  | &nbsp;&nbsp; **122817809** | &nbsp;&nbsp; **—** | &nbsp;&nbsp; **—** | &nbsp;&nbsp; **122817809** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>†</sup> *See Schedule of Investments for additional detailed categorizations, if any.*

**5**

------

The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") is the exclusive reference of authoritative U.S. generally accepted accounting principles ("GAAP") recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission ("SEC") under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund's financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund's investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

**Level 1**—unadjusted quoted prices in active markets for identical investments.

**Level 2**—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

**Level 3**—significant unobservable inputs (including the fund's own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund's investments are as follows:

BNY Mellon ETF Trust II's (the "Trust") Board of Trustees (the "Board") has designated the Adviser as the fund's valuation designee to make all fair value determinations with respect to the fund's portfolio of investments, subject to the Board's oversight and pursuant to Rule 2a-5 under the Act.

Investments in equity securities, including shares of REITs and ETFs (but not including investments in other open-end registered investment companies), generally are valued at the last sales price on the day of valuation of the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Association of Securities Dealers Automated Quotation System ("NASDAQ") markets generally will be valued at the official closing price. If there are no transactions in a security, or no official closing prices for a NASDAQ market-listed security on that day, the security will be valued at the average of the most recent bid and asked prices. Bid price is used when no asked price is available. Open short positions for which there is no sale price on a given day are valued at the lowest asked price. Investments in other open-end investment companies are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to reflect fair value accurately, are valued at fair value as determined in good faith based on procedures approved by the Board. Fair value of investments may be determined by valuation designee using such information as it deems appropriate under the circumstances. The factors that may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. Using fair value to price investments may result in a value that is different from a security's most recent closing price and from the prices used by other funds to calculate their net asset values. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and are generally categorized within Level 3 of the fair value hierarchy.

Pursuant to a securities lending agreement with BNY, the fund may lend securities to qualified institutions. It is the fund's policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign

**6**

------

securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by the Adviser, or U.S. Government and Agency securities. The securities on loan, if any, are also disclosed in the fund's Schedule of Investments. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to income earned as a result of the lending transaction. Should a borrower fail to return the securities in a timely manner, BNY is required to replace the securities for the benefit of the fund or credit the fund with the market value of the unreturned securities and is subrogated to the fund's rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis.

At January 31, 2026, accumulated net unrealized appreciation on investments was $60,938,083, consisting of $61,475,755 gross unrealized appreciation and $537,672 gross unrealized depreciation.

At January 31, 2026, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Schedule of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.

**7**

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** BNY Mellon ETF Trust II

- **b. Investment Company Act file number:** 811-23977

- **c. CIK number of Registrant:** 0002025968

- **d. LEI of Registrant:** 2549008HP0U9LCUPA319

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 240 Greenwich Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10286

  - **Telephone number:** 212-922-6400

**Item A.2. Information about the Series.**

- **a. Name of Series:** BNY Mellon Concentrated Growth ETF

- **b. EDGAR series identifier (if any):** S000087737

- **c. LEI of Series:** 2549006BJ141PEYF2136

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-10-31

- **b. Date as of which information is reported:** 2026-01-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $122938997.62

**Total Liabilities:** $1005727.21

**Net Assets:** $121933270.41

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000253638 | -0.35%               | 0.88%                | 1.93%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $426470.83               | $-874983.34                                |
| Month 2  | $868652.60               | $94451.50                                  |
| Month 3  | $875817.16               | $1256527.13                                |

### Schedule of Portfolio Investments

| Name                                                         | Title                                                        | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Visa Inc                                                     | Visa Inc                                                     | CUSIP: 92826C839<br>LEI: 549300JZ4OKEHW3DPJ59 | Long             | EC               | CORP              | US        |     11527 | NS      | $3709734.41   | 3.04%             |  |  |  | No            |                  1 | On Loan: —       |
| BAE Systems PLC                                              | BAE Systems PLC                                              | CUSIP: 05523R107<br>LEI: 8SVCSVKSGDWMW2QHOH83 | Long             | EC               | CORP              | GB        |     35035 | NS      | $3807603.80   | 3.12%             |  |  |  | No            |                  1 | On Loan: —       |
| LVMH Moet Hennessy Louis Vuitt                               | LVMH Moet Hennessy Louis Vuitton SE                          | CUSIP: 502441306<br>LEI: IOG4E947OATN0KJYSD45 | Long             | EC               | CORP              | FR        |     10355 | NS      | $1338694.40   | 1.10%             |  |  |  | No            |                  1 | On Loan: —       |
| AstraZeneca PLC                                              | AstraZeneca PLC                                              | CUSIP: 046353108<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |     28855 | NS      | $2676878.35   | 2.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Eaton Corp PLC                                               | Eaton Corp PLC                                               | CUSIP: 000000000<br>LEI: 549300VDIGTMXUNT7H71 | Long             | EC               | CORP              | IE        |      9383 | NS      | $3297373.86   | 2.70%             |  |  |  | No            |                  1 | On Loan: No      |
| TSMC                                                         | Taiwan Semiconductor Manufacturing Co Ltd                    | CUSIP: 874039100<br>LEI: 549300KB6NK5SBD14S87 | Long             | EC               | CORP              | TW        |     10329 | NS      | $3414354.24   | 2.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Home Depot Inc/The                                           | Home Depot Inc/The                                           | CUSIP: 437076102<br>LEI: QEKMOTMBBKA8I816DO57 | Long             | EC               | CORP              | US        |      8025 | NS      | $3006084.75   | 2.47%             |  |  |  | No            |                  1 | On Loan: No      |
| NVIDIA Corp                                                  | NVIDIA Corp                                                  | CUSIP: 67066G104<br>LEI: 549300S4KLFTLO7GSQ80 | Long             | EC               | CORP              | US        |     60772 | NS      | $11615352.36  | 9.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Intercontinental Exchange Inc                                | Intercontinental Exchange Inc                                | CUSIP: 45866F104<br>LEI: 5493000F4ZO33MV32P92 | Long             | EC               | CORP              | US        |     17429 | NS      | $3028811.62   | 2.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Philip Morris International In                               | Philip Morris International Inc                              | CUSIP: 718172109<br>LEI: HL3H1H2BGXWVG3BSWR90 | Long             | EC               | CORP              | US        |     21050 | NS      | $3777212.00   | 3.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuit Inc                                                   | Intuit Inc                                                   | CUSIP: 461202103<br>LEI: VI90HBPH7XSFMB9E4M29 | Long             | EC               | CORP              | US        |      6659 | NS      | $3322308.28   | 2.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Alphabet Inc                                                 | Alphabet Inc                                                 | CUSIP: 02079K107<br>LEI: 5493006MHB84DD0ZWV18 | Long             | EC               | CORP              | US        |     27216 | NS      | $9213432.48   | 7.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Texas Instruments Inc                                        | Texas Instruments Inc                                        | CUSIP: 882508104<br>LEI: WDJNR2L6D8RWOEB8T652 | Long             | EC               | CORP              | US        |     13837 | NS      | $2982565.35   | 2.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Meta Platforms Inc                                           | Meta Platforms Inc                                           | CUSIP: 30303M102<br>LEI: BQ4BKCS1HXDV9HN80Z93 | Long             | EC               | CORP              | US        |      7872 | NS      | $5640288.00   | 4.63%             |  |  |  | No            |                  1 | On Loan: No      |
| ServiceNow Inc                                               | ServiceNow Inc                                               | CUSIP: 81762P102<br>LEI: 549300HJTQM36M0E1G39 | Long             | EC               | CORP              | US        |     14814 | NS      | $1733386.14   | 1.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Apple Inc                                                    | Apple Inc                                                    | CUSIP: 037833100<br>LEI: HWUPKR0MPOU8FGXBT394 | Long             | EC               | CORP              | US        |     21150 | NS      | $5488002.00   | 4.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Dreyfus Institutional Preferred Government Money Market Fund | Dreyfus Institutional Preferred Government Money Market Fund | CUSIP: 26200X100<br>LEI: 549300RBWL04JG8SIX57 | Long             | STIV             | RF                | US        |   4533596 | NS      | $4533595.58   | 3.72%             |  |  |  | No            |                  1 | On Loan: No      |
| ASML Holding NV                                              | ASML Holding NV                                              | CUSIP: 000000000<br>LEI: 724500Y6DUVHQD6OXN27 | Long             | EC               | CORP              | NL        |      5302 | NS      | $7544746.00   | 6.19%             |  |  |  | No            |                  1 | On Loan: No      |
| S&P Global Inc                                               | S&P Global Inc                                               | CUSIP: 78409V104<br>LEI: Y6X4K52KMJMZE7I7MY94 | Long             | EC               | CORP              | US        |      4157 | NS      | $2194023.03   | 1.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Blackrock Inc                                                | Blackrock Inc                                                | CUSIP: 09290D101<br>LEI: 529900VBK42Y5HHRMD23 | Long             | EC               | CORP              | US        |      3582 | NS      | $4008043.08   | 3.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Mastercard Inc                                               | Mastercard Inc                                               | CUSIP: 57636Q104<br>LEI: AR5L2ODV9HN37376R084 | Long             | EC               | CORP              | US        |      8961 | NS      | $4828097.19   | 3.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Microsoft Corp                                               | Microsoft Corp                                               | CUSIP: 594918104<br>LEI: INR2EJN1ERAN0W5ZP974 | Long             | EC               | CORP              | US        |     17274 | NS      | $7432829.46   | 6.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Amazon.com Inc                                               | Amazon.com Inc                                               | CUSIP: 023135106<br>LEI: ZXTILKJKG63JELOEG630 | Long             | EC               | CORP              | US        |     37525 | NS      | $8979732.50   | 7.36%             |  |  |  | No            |                  1 | On Loan: No      |
| DREY INST PREF GOV MM-M                                      | DREY INST PREF GOV MM-M                                      | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |    953788 | NS      | $953788.40    | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                                               | Eli Lilly & Co                                               | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |      4808 | NS      | $4986617.20   | 4.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Deere & Co                                                   | Deere & Co                                                   | CUSIP: 244199105<br>LEI: PWFTNG3EI0Y73OXWDH08 | Long             | EC               | CORP              | US        |      4961 | NS      | $2619408.00   | 2.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical Inc                                       | Intuitive Surgical Inc                                       | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |      7959 | NS      | $4013086.98   | 3.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Progressive Corp/The                                         | Progressive Corp/The                                         | CUSIP: 743315103<br>LEI: 529900TACNVLY9DCR586 | Long             | EC               | CORP              | US        |     12845 | NS      | $2671760.00   | 2.19%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-03-25

**Name of Applicant:** BNY Mellon ETF Trust II

**Signature:** James Windels

**Name of Signer:** James Windels

**Title:** Treasurer